MetaCap

Electra Therapeutics (ETRA) vs 4D Molecular Therapeutics (FDMT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.

Summary

4D Molecular Therapeutics is the larger company by market cap ($695.5 million vs $574.9 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ETRA-30.87%FDMT-17.28%
+7%-13%-33%
Sep 18, 20261 yearOct 7, 2026
ETRA-30.87%FDMT-17.28%
+2%-15%-32%
Sep 14, 20265 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ETRA versus FDMT key metrics
MetricETRAFDMT
Share price$9.16$12.59
Market cap$574.95M$695.52M
1-day change-6.72%+0.24%
YTD return—+67.87%
1-year return—+51.32%
5-year return—-53.92%
EPS (TTM)$-2.65$-2.63
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$15.50$16.93
52-week low$8.92$6.96
Distance from 52-week high-40.90%-25.63%
Average volume990.55K924.05K
Shares outstanding62.77M55.24M
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

ETRA vs FDMT FAQ

Which is bigger, Electra Therapeutics or 4D Molecular Therapeutics?

4D Molecular Therapeutics (FDMT) is larger, with a market capitalization of $695.52M compared with $574.95M for Electra Therapeutics (ETRA).

Are Electra Therapeutics and 4D Molecular Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons